Brief: Victory Square-Granted FDA Permission In U.S. To Commence Marketing, Sales& Distribution Under Emergency Use Authorization For Safetest Covid-19 Assay
25/08/2020 13:54
Aug 25 (Reuters) - Victory Square Technologies Inc VST.CD :
* VICTORY SQUARE-GRANTED FDA PERMISSION IN U.S. TO COMMENCE
MARKETING, SALES& DISTRIBUTION UNDER EMERGENCY USE AUTHORIZATION
FOR SAFETEST COVID-19 ASSAY
Source text for Eikon: ID:nGNX8wRF3v
Further company coverage: VST.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Victory Square Technologies
See all newsCanada's Victory Square Q2 revenue jumps on Hydreight strength
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Technologies Declares Special Common Share Dividend Of Its Interest In Yocale.ai
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent